CYMBALTA caps 30 mg 28 pce
7680569830060
CH-56983
N06AX21
01.06.0.
1 / 3
google
Details
- Product number
- 5698301
- CPT
- -
- Packaging group
- 28
- Unit
- Kapsel(n)
- Composition
- duloxetinum 30 mg ut duloxetini hydrochloridum, saccharum, hypromellosi acetas succinas, hypromellosum, sacchari sphaerae, talcum, triethylis citras, E 171, matériel de la capsule: E 132, E 171, gelatina, natrii laurilsulfas, encre: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), E 172 (flavum), pro capsula corresp. saccharum 56 mg, natrium 0.0055 mg.
Articles (1)
Cymbalta 30 mg, gélules gastrorésistantes
Kapseln
28
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
duloxetinum
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
duloxetini hydrochloridum
|
- | Substance | WIZUS |
|
saccharum
|
- | Substance | HNIDK |
|
hypromellosi acetas succinas
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
sacchari sphaerae
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
triethylis citras
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 132
|
- | Substance | FIMDK |
|
E 171
|
- | Substance | FNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
lacca
|
- | Substance | HNIDK |
|
propylenglycolum
|
- | Substance | HNIDK |
|
kalii hydroxidum
|
- | Substance | HNIDK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
saccharum
|
56.0 MG | Substance | HBESI |
|
natrium
|
0.0055 MG | Substance | HBESI |
Authorization holder
Eli Lilly (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 56983
- Drug name
- Cymbalta, gélules gastrorésistantes
- Galenic form
- KAHAM
- ATC Code
- N06AX21
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 24/11/2005
- Authorization expiration date
- 01/06/2026
- IT number
- 01.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CYMBALTA caps 30 mg 28 pce
- Description (DE)
- CYMBALTA Kaps 30 mg 28 Stk
- Market launch
- 24/11/2005
- Market withdrawal
- 30/11/2025
- Narcotic (BTM)
- No